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 DECLARATION (37 CFR 1.63) FOR UTILITY OR DESIGN APPLICATION USING AN 
   APPLICATION DATA SHEET (37 CFR 1.76) 
                                                                   
                                                               
 
 PTO/AIA/01 (06-12) 
Approved for use through 01/31/2014.  OMB 0651-0032 
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE 
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. 
Title of 
Invention 
As the below named inventor, I hereby declare that: 
This declaration 
is directed to: The attached application, or 
United States application or PCT international application number ________________________ 
filed on ________________________________.
The above-identified application was made or authorized to be made by me. 
I believe that I am the original inventor or an original joint inventor of a claimed invention in the application. 
I hereby acknowledge that any willful false statement made in this declaration is punishable under 18 U.S.C. 1001 
by fine or imprisonment of not more than five (5) years, or both. 
WARNING: 
Petitioner/applicant is cautioned to avoid submitting personal information in documents filed in a patent application that may 
contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card numbers 
(other than a check or credit card authorization form PTO-2038 submitted for payment purposes) is never required by the USPTO 
to support a petition or an application. If this type of personal information is included in documents submitted to the USPTO, 
petitioners/applicants should consider redacting such personal information from the documents before submitting them to the 
USPTO. Petitioner/applicant is advised that the record of a patent application is available to the public after publication of the 
application (unless a non-publication request in compliance with 37 CFR 1.213(a) is made in the application) or issuance of a 
patent. Furthermore, the record from an abandoned application may also be available to the public if the application is 
referenced in a published application or an issued patent (see 37 CFR 1.14). Checks and credit card authorization forms 
PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly available. 
LEGAL NAME OF INVENTOR 
Inventor: ___________________________________________________ Date (Optional) :_______________________ 
nature: __________________________________________________________________________________Sig ______ 
Note: An application data sheet (PTO/SB/14 or equivalent), including naming the entire inventive entity, must accompany this form or must have 
been previously filed.  Use an additional PTO/AIA/01 form for each additional inventor. 
This collection of information is required by 35 U.S.C. 115 and 37 CFR 1.63. The information is required to obtain or retain a benefit by the public which is to file (and 
by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1 minute to 
complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any 
comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. 
Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO 
THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. 
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2. 
 
   
Privacy Act Statement 
The Privacy Act of 1974 (P.L. 93-579)  requires that you be given certain information in connection 
with your submission of the attached form related to a patent application or patent. Accordingly, 
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the 
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; 
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do 
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to 
process and/or examine your submission, which may result in termination of proceedings or 
abandonment of the application or expiration of the patent. 
The information provided by you in this form will be subject to the following routine uses: 
1. 	 The information on this form will be treated confidentially to the extent allowed under the 
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from 
this system of records may be disclosed to the Department of Justice to determine whether 
disclosure of these records is required by the Freedom of Information Act. 
2. 	 A record from this system of records may be disclosed, as a routine use, in the course of 
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to 
opposing counsel in the course of settlement negotiations. 
3. 	 A record in this system of records may be disclosed, as a routine use, to a Member of 
Congress submitting a request involving an individual, to whom the record pertains, when the 
individual has requested assistance from the Member with respect to the subject matter of the 
record. 
4. 	 A record in this system of records may be disclosed, as a routine use, to a contractor of the 
Agency having need for the information in order to perform a contract. Recipients of 
information shall be required to comply with the requirements of the Privacy Act of 1974, as 
amended, pursuant to 5 U.S.C. 552a(m). 
5. 	 A record related to an International Application filed under the Patent Cooperation Treaty in 
this system of records may be disclosed, as a routine use, to the International Bureau of the 
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty. 
6. 	 A record in this system of records may be disclosed, as a routine use, to another federal 
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to 
the Atomic Energy Act (42 U.S.C. 218(c)). 
7. 	 A record from this system of records may be disclosed, as a routine use, to the Administrator, 
General Services, or his/her designee, during an inspection of records conducted by GSA as 
part of that agency's responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall 
be made in accordance with the GSA regulations governing inspection of records for this 
purpose, and any other relevant ( i.e., GSA or Commerce) directive. Such disclosure shall not 
be used to make determinations about individuals. 
8. 	 A record from this system of records may be disclosed, as a routine use, to the public after 
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent 
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is 
referenced by either a published application, an application open to public inspection or an 
issued patent. 
9. 	 A record from this system of records may be disclosed, as a routine use, to a Federal, State, 
or local law enforcement agency, if the USPTO becomes aware of a violation or potential 
violation of law or regulation. 
